TPG Weighs $5B Sale of Healthcare Software Firm Lyric

Private equity firm TPG is evaluating a sale of Lyric, its healthcare software portfolio company, in a deal that could value the firm at approximately $5 billion, according to a Reuters report. The potential transaction signals renewed appetite in the healthcare technology sector as strategic buyers and rival PE firms seek scaled software assets.

Lyric operates in the healthcare software space, a segment that has drawn sustained investment interest given the industry's ongoing push toward digital transformation, data interoperability, and cost containment. A $5 billion valuation would represent a significant exit for TPG, underscoring how premium multiples have persisted for healthcare IT assets even as broader deal markets have cooled.

Read more Sub-$100 Smartphones Disappearing as AI Drives Up Memory Costs →

TPG, one of the largest alternative asset managers in the United States, has built a notable healthcare and technology investment franchise over the past decade. The firm's consideration of a Lyric sale fits a broader pattern of PE sponsors testing exit windows as interest rate pressures and credit market conditions gradually ease heading into the second half of 2025.

No deal has been confirmed, and the outcome of any formal process remains uncertain. Sources familiar with such processes note that strategic acquirers — including large health systems, insurers, and enterprise software companies — as well as secondary PE buyers could emerge as potential bidders if TPG moves forward with a formal auction.

Continue reading at SeekingAlpha.